出版空间以及编辑关注度的竞争异常激烈。将原稿投送给杂志编辑，附上一封信“原稿请见附件”是远远不够的。投稿信是你与拟投杂志直接交流的机会。除了写明你的研究与众不同外，还应直接向总编辑说明为什么你的发现很重要及其应该在此杂志上发表的理由。 投 稿信应含有几个重要内容。具体内容可通过www.liwenbianji.cn/coverletter 链接下载。大家可根据批注中的建议起草你自己的投稿信，选择提出的句子类型替代括号中的句子。投稿信的格式几乎适用于所有投稿；当然，某些类别的论文需要 加入额外的内容。例如，关于临床试验数据的存储信息通常需要附上一份临床试验报告，提供你的序列数据进入公共数据库的信息。 查阅目标杂志 的《稿约》是每篇稿件的既定程序，其中很可能含有投稿信必须写入的内容。另外一个信息来源是杂志的投稿网页。尽管以下列出的内容以及关于“Edanz投稿 信模版”中描述的内容不一定完全都是这些目标杂志所要求的，但所有这些都是投稿信中必不可少的，因为这样做可引起编辑对你的关注。以下方法适用于投稿信的 撰写： • 一些杂志根据其刊出文章领域的不同进行编辑分工，你可以根据不同的领域，有时也可根据编辑的专业背景选择最合适的编辑。直接称呼收信编辑，如：“Dear Dr. Smith”。如果不能找到合适的编辑，可将投稿信写给总编辑。 • 信的开头应写出文章题目，希望文章在杂志的哪一个栏目或作为哪一个文章类别发表，以及投稿杂志的名称。 • 之后简单叙述研究背景与理论基础，说明研究目的以及开展的工作。然后简单描述研究成果。 • 接下来的段落很重要。你需要向研究界解释你的发现的意义，特别是对杂志读者的意义。如果你不能解释为什么该杂志读者会对你的发现感兴趣，你需要选择另一家 更合适的刊物，因为编辑只将他们认为会引起读者兴趣的文章送同行评议。研究一下你准备投稿杂志的“目标与刊出范围”会对你有帮助。 • 投稿信的最后一段应包含杂志所要求的声明或说明。这些通常包括关于利益冲突、基金资助与资助来源的声明，以及所有作者已阅读过并同意文章的内容以及未一稿多投的声明。每个作者的作者资格确认也是需要的。 • 最后，留下详细的通讯方式以及礼貌的结束语。 示例： 英文原文 The cover letter: your sales pitch Competition for publication space and for editors’ attention is now very high, and it is no longer sufficient to send a manuscript to a journal editor along with a letter saying little more than “please find my manuscript attached”. The cover letter is your opportunity to directly address the editor of your target journal. It can be used to set your study apart from others and directly explain to the editor why your findings are important and why they should be published in their journal. There are a number of important components of a cover letter, all of which should be included. These components are described in detail in Edanz Cover Letter Template, which is shown on the following page and can be downloaded from: www.liwenbianji.cn/coverletter. This template can be used to develop your own cover letters by following the suggestions in the comments and replacing the bracketed sentences with the types of sentences explained. The format of this letter is applicable for most if not all submissions, although additional sections may be required for some types of paper; for example, information about deposition of clinical trial data would most likely need to accompany a report of a clinical trial, and information about the deposition of sequence data into public databases would possibly need to be provided where such data has been obtained. As always, the target journal’s instructions to authors should be consulted; these will most likely outline the information that absolutely must be included in the cover letter. Another source of this information is the journal’s submission webpages. Although not all of the components listed below and described in the cover letter template will be described as required on the target journal’s webpages, all should be included in your letter, because to do so will increase your chances of grabbing the editor’s attention. The following principles apply to cover letter development: • Some journals have different editors for the different areas of research the journal covers and you can choose the most appropriate one based on area and occasionally also editor profiles. Address your letter personally to the appropriate editor, e.g., “Dear Dr. Smith”. If one cannot be readily identified, address your letter to the editor-in-chief. • Begin by providing the title of your manuscript, the section/publication type you would like to see it published as, and the name of the journal you are submitting it to. • You then need to provide a very brief background and rationale for your study, explaining why you did what you did. This can be followed by a brief description of the results. • The following paragraph is very important. You will need to explain the significance of your findings to the research community, and specifically to the readers of your target journal. If you find it difficult to explain why the readers of that journal would be interested in your findings, then you may need to select a more appropriate journal. Editors will only send papers to review that they think will be of interest to their readers. Studying the ‘aims and scope’ of your chosen journal might help with this. • The last paragraph of the letter should contain any statements or declarations required by the target journal. These usually include declarations of any conflicts of interest, grant support or other sources of funding, a statement that all authors have read and approved the manuscript and a statement that the same manuscript has not been submitted elsewhere. Confirmation of each author’s qualification for authorship may also be required. • Finally, include details for correspondence and a polite farewell. Example: Dr Daniel McGowan 分子神经学博士 理文编辑学术总监
出版空间以及编辑关注度的竞争异常激烈。将原稿投送给杂志编辑，附上一封信“原稿请见附件”是远远不够的。投稿信是你与拟投杂志直接交流的机会。除了写明你的研究与众不同外，还应直接向总编辑说明为什么你的发现很重要及其应该在此杂志上发表的理由。 投 稿信应含有几个重要内容。具体内容可通过www.liwenbianji.cn/coverletter 链接下载。大家可根据批注中的建议起草你自己的投稿信，选择提出的句子类型替代括号中的句子。投稿信的格式几乎适用于所有投稿；当然，某些类别的论文需要 加入额外的内容。例如，关于临床试验数据的存储信息通常需要附上一份临床试验报告，提供你的序列数据进入公共数据库的信息。 查阅目标杂志 的《稿约》是每篇稿件的既定程序，其中很可能含有投稿信必须写入的内容。另外一个信息来源是杂志的投稿网页。尽管以下列出的内容以及关于“Edanz投稿 信模版”中描述的内容不一定完全都是这些目标杂志所要求的，但所有这些都是投稿信中必不可少的，因为这样做可引起编辑对你的关注。以下方法适用于投稿信的 撰写： • 一些杂志根据其刊出文章领域的不同进行编辑分工，你可以根据不同的领域，有时也可根据编辑的专业背景选择最合适的编辑。直接称呼收信编辑，如：“Dear Dr. Smith”。如果不能找到合适的编辑，可将投稿信写给总编辑。 • 信的开头应写出文章题目，希望文章在杂志的哪一个栏目或作为哪一个文章类别发表，以及投稿杂志的名称。 • 之后简单叙述研究背景与理论基础，说明研究目的以及开展的工作。然后简单描述研究成果。 • 接下来的段落很重要。你需要向研究界解释你的发现的意义，特别是对杂志读者的意义。如果你不能解释为什么该杂志读者会对你的发现感兴趣，你需要选择另一家 更合适的刊物，因为编辑只将他们认为会引起读者兴趣的文章送同行评议。研究一下你准备投稿杂志的“目标与刊出范围”会对你有帮助。 • 投稿信的最后一段应包含杂志所要求的声明或说明。这些通常包括关于利益冲突、基金资助与资助来源的声明，以及所有作者已阅读过并同意文章的内容以及未一稿多投的声明。每个作者的作者资格确认也是需要的。 • 最后，留下详细的通讯方式以及礼貌的结束语。 示例： 英文原文 The cover letter: your sales pitch Competition for publication space and for editors’ attention is now very high, and it is no longer sufficient to send a manuscript to a journal editor along with a letter saying little more than “please find my manuscript attached”. The cover letter is your opportunity to directly address the editor of your target journal. It can be used to set your study apart from others and directly explain to the editor why your findings are important and why they should be published in their journal. There are a number of important components of a cover letter, all of which should be included. These components are described in detail in Edanz Cover Letter Template, which is shown on the following page and can be downloaded from: www.liwenbianji.cn/coverletter. This template can be used to develop your own cover letters by following the suggestions in the comments and replacing the bracketed sentences with the types of sentences explained. The format of this letter is applicable for most if not all submissions, although additional sections may be required for some types of paper; for example, information about deposition of clinical trial data would most likely need to accompany a report of a clinical trial, and information about the deposition of sequence data into public databases would possibly need to be provided where such data has been obtained. As always, the target journal’s instructions to authors should be consulted; these will most likely outline the information that absolutely must be included in the cover letter. Another source of this information is the journal’s submission webpages. Although not all of the components listed below and described in the cover letter template will be described as required on the target journal’s webpages, all should be included in your letter, because to do so will increase your chances of grabbing the editor’s attention. The following principles apply to cover letter development: • Some journals have different editors for the different areas of research the journal covers and you can choose the most appropriate one based on area and occasionally also editor profiles. Address your letter personally to the appropriate editor, e.g., “Dear Dr. Smith”. If one cannot be readily identified, address your letter to the editor-in-chief. • Begin by providing the title of your manuscript, the section/publication type you would like to see it published as, and the name of the journal you are submitting it to. • You then need to provide a very brief background and rationale for your study, explaining why you did what you did. This can be followed by a brief description of the results. • The following paragraph is very important. You will need to explain the significance of your findings to the research community, and specifically to the readers of your target journal. If you find it difficult to explain why the readers of that journal would be interested in your findings, then you may need to select a more appropriate journal. Editors will only send papers to review that they think will be of interest to their readers. Studying the ‘aims and scope’ of your chosen journal might help with this. • The last paragraph of the letter should contain any statements or declarations required by the target journal. These usually include declarations of any conflicts of interest, grant support or other sources of funding, a statement that all authors have read and approved the manuscript and a statement that the same manuscript has not been submitted elsewhere. Confirmation of each author’s qualification for authorship may also be required. • Finally, include details for correspondence and a polite farewell. Example: Dr Daniel McGowan 分子神经学博士 理文编辑学术总监
PNAS建议稿件投稿前最好不要online贴出 网上贴出的稿件，是否还能再投纸张期刊？ 真傻一直弄不很清楚。尽管英语很蹩脚，还是向PNAS（The Proceedings of the National Academy of Sciences of the United States of America）去email打听。 感谢PNAS好心的回复！现贴在下面。 发件人： PNAS PNAS@nas.edu 主 题： RE: Inquire, ZL Yang 日 期： Thu, 24 Mar 2011 10:21:50 -0400 Dr. Yang, Thank you for your email to PNAS. All published manuscripts are made available online at no charge after 6 months following publication. The surcharge of 1,275 is for those authors who want to make their manuscript available online immediately at the time of publication. Regarding your other question, although PNAS cannot prevent authors from making their papers available online prior to submission, it is strongly advised to not do so. Although PNAS policy only explicitly states that papers may not be submitted to other journals at the same time as PNAS, it is suggested that you do not make the information public prior to official publication. If you do choose to make a manuscript publicly available prior to submission to PNAS, this should be disclosed with the submission. Kind Regards, Mitch Sipus PNAS Editorial Office Sent: Wednesday, March 23, 2011 9:41 PM To: PNAS Subject: Inquire, ZL Yang Dear Editor, If a paper (draft) has been published in a Website, such as the arXiv ( www.arxiv.org/ ) or the Sciencepaper Online ( http://www.paper.edu.cn/en ), can this paper be submitted to PNAS again? I found some authors first published their papers in the arXiv, then submitted papers to some JOURNALS, such as Physical Review Letters. I wonder if they were no trouble. Besides, "Authors of research articles may pay a surcharge of $1,275 to make their paper freely available through PNAS open access option." If the $1,275 can not be paid, can the paper be published in the traditional papery PNAS only? Thank you! Best regards, Zheng-Ling YANG PhD, associate professor, Tianjin University, Tianjin, China
对于 《浙江大学学报（英文版）》（ Journal of Zhejiang UniversityScience ）编辑部主任张月红 9 月 9 日 发表在奶车（ Nature 即《自然》）杂志的通信称 Chinese journal finds 31% of submissions plagiarized （《中国期刊发现投稿中 31% 为剽窃》），李小文院士曾发表题为《 请教张月红：打黑还是黑打 》的博文进行驳斥。李小文院士写到： 反抄袭，反剽窃，绝对支持。但是给人定罪要郑重。回顾张月红主任在 科学时报 2009-5-6 发表的文章： 几个月的工作过程中，通过 CrossCheck 对不同体裁论文相似度标准的初步分析和确定，实事求是地说，大多数投向《浙江大学学报》的论文作者是秉着严谨治学的态度的，其论文相似度比较低。然而，确有 20% 的文章由于各种原因具有一定程度不合理的抄用他人之句和自我抄袭等表现，其中约 5% 的文章甚至严重涉及剽窃和版权之嫌，个别文章甚至达 50% 以上的相似度 。 好像还是比较郑重的，怎么过了一年多一点，就变成 31% 的投稿存在剽窃 了呢？张月红主任应该给大家一个解释。 在随后的 《 再请教张月红：n ＝？ 》一文中， 李小文院士 更问： 产生 科学时报 2009-5-6 文章数据和产生《自然》杂志通讯数据的 n 设定是同样的吗 ？ 中国科学院动物研究所研究员 王德华的博客 发表《 《浙江大学学报》的问题不能代表中国的主流期刊 》，表示 不解为什么这样的稿件会在《自然》发表，更认为文章的题目是完全错误的。 对于 《自然》发表《中国期刊发现投稿中 31% 为剽窃》这样题目的通讯， 张月红作了如下的 说明 ： 关于标题的来由： 1. Policing plagiarism in China is helped by innovative software （创新软件帮助中国编辑应对抄袭 ) （这是经作者最后校对的标题及内容：见校对附件 http://www.zju.edu.cn/jzus/download/Correspondence_proof.pdf ） 2. Chinese journal finds 31% of submissions plagiarized （中国某期刊检测出 31%的投稿中有抄袭现象） （这是《自然》编辑在最后一刻改定的标题及内容，见附件： http://www.zju.edu.cn/jzus/download/Correspondence.pdf ，未经作者校对，见《自然》编辑经作者申诉后来信的部分内容: .This was a last-minute change by one of the senior editors. Because your letter mentions only JZUS, we expect it will be clear to the majority of readers that the 31% figure refers only to that journal. I'm sorry that I cannot be of more help. 《Nature》的这篇通讯引发了一场 大争论 《Nature》的这篇通讯引发了一场 大争论 ，而《Nature》编辑 未经作者同意擅改其文章标题的做法更被网友戏为奶车对牛奶进行勾对。 更时髦一点说就是标题党的《 所谓语不惊人死不休 》， 因为这篇通讯只是简单介绍了Journal of Zhejiang UniversityScience 使用CrossCheck的情况，而且也没有认定这31%的投稿都是剽窃。那为什么要起这样一个题目啊？ 对此，自称求真皇帝的超一流科学家、被方舟子称为高人的刘实一针见血地指出：《 月红妹被人当枪使了，应挺起胸脯反戈一击 》。刘实查证：《 plagiarism是源于西方文化的绅士剽窃 》。刘实还《 建议月红妹Crosscheck《自然》已发文章并报结果 》。 我在 9 月9日 奶车发表通信 的当天就发了 《 Nature 上发了一篇题目荒唐的通讯(Correspondence) 》一文。并主动与刘实联系，表示应写一篇 通信给 《Nature》。而刘实当即就回信，称他已写了个稿子（英文的），但没法投给 奶车，因为奶车已表明了不再收刘奶。他要我看下这稿子，如同意，就由我来修改后投稿。 刘实与 李小文院士 和王德华 研究员 也取得了联系，他们两位也愿当共同作者。 所以，经过大家几个来回的修改，最终我代表大家在9月12日发给Nature编辑部一份题为《Dont blame ancient Chinese culture for modern evils in science》的短信（Correspondence）。9月17日Nature编辑部来函表示接受发表，9月22日我们收到了编辑部发来的校对稿，打开一看编辑修改的短信只剩下了一句话，完全篡改了我们短信的意思。我们当然不同意，经反复协商写出了我们自己的修改稿于9月24日发给编辑部。此后近两周没有任何消息。10月5日我发E-mail查询，10月6日编辑部来信说不发了（详情见《 Nature 如此处理读者来信 》、《 差一点就在 Nature 上发 文章 了 》、《 再说 差一点就在Nature发文章了 》）。 现在看来，我们还是应当克己复礼才是，应当先让《Nature》发个短信，其它事以后再说。（见《 就不当地下奶车向共同作者作个自然的道歉 》），不过 王德华 研究员发表了 《 Nature 拒稿感想：不遗憾，谢博友 》，并进一步指出《 张月红编辑应该让 Nature 进一步认错 》。 其实，让 《 Nature》认错是几乎不可能的事。因为我最近发现战奶车的 刘实恐怕已被 奶车压死（见《 肖案判了、《自然》论了、刘实哑了？ 》、《 求真皇帝遇难，造假皇帝称雄 》）。 不过，如果张月红主动去信要求撤稿，可能还有希望消除《Nature》对中国科学腐败的重判。 现在， 《Nature》所称的中国期刊 三分之一来稿抄袭已被方舟子引用并放大到 大陆学术界三分之一人造假 。而这一结论正被方迷们广为传播。如 水博 就 转载 了《 世界日报》发表的《 大陆学术界约三分之一人造假 》一文。而网友在此文下留的一些评论还是有道理的： 标题： 发表评论人： sc z ip:18.82.5.* 《浙江大学学报（英文版）》的论文，有 60% 来自境外学者稿件 ，跟 大陆学术界约 1/3 文造假 两者之间有什么逻辑关联？这是关于两件事情的两个个人陈述。 标题： 发表评论人： jihua0a 方不群还是老实交代在中科大的假侨属证明事情吧。 还有，方不群自己的几次摘抄及翻译别人文章不注明原作者和出处的行为，本身就是剽窃行为，自己先把自己的屁股擦干净吧。 标题： 发表评论人： 抗议 ip:61.185.221.* 张月红已指出，投《浙江大学学报（英文版）》的论文，有 60% 来自境外学者稿件。方舟之还丧心病狂地说：大陆学术界约 1/3 文造假。这简直就是一个疯狗，是一个对中国怀有敌意和不择手段污蔑的疯狗。 标题： 发表评论人： jihua0a 方舟子 博士故意把 (In early trials, doctors in the United States who have done the surgery have found the results to be far more promising.) 删掉。 纽约时报文章这段文章透露：在美国的早期临床试验中，做过手术的医生们发现其结果是很有前途的。 http://blog.sina.com.cn/s/blog_6d84b1b90100mou9.html 标题： 发表评论人： 科学发展观 ip:61.138.129.* 方舟子会美国主子哪里去邀功请赏去了，也是接受下一步行动指示。他先把自己的画皮揭下来吧。
08年11月28日给Acta Mater投了一篇文章，当时推荐了4位审稿人，1位是英国的老院士，2位是美国的领域内知名教授，1位是国内此领域的领军人物。 第二天就送审了（窃喜，第一关终于过了）。 Under review 大概1个月后，状态变了，似乎是审完了，蛮以为马上就能等到decision letter. 结果是又变成 under review了，没办法再等了。 09年2月11号的时候，终于来了Comment. 结果发现就只有一个审稿人，意见是: This is a very interesting paper and is certainly worthy of publication. It would benefit from consideration of the following points: 1.......... 2. p 5 line 7 ....... 3. the authors may very well be correct about 'an alternative mechanism' for shear banding instability (page 6/7 turnover), but have they done any Recht-type calculations to show that the usual mechanism is inappropriate? 4. p 8 top omission of separation energy. .......... ============ 意见总算还行，好好修改还是希望蛮大的。但是，有个疑问，Acta Mater就一个审稿人么？ 还是因为前面已经送审，没有实质性意见，同意发表。编辑又找了第3审稿人进行审稿了？ 从审稿意见，我马上知道了，这个审稿人就是我们推荐的那一位英国院士。 跟导师讨论了一次后，准备了cover letter, response letter and revised manuscript. 昨天晚上（2.19）通过在线投稿系统提交了过去。 今天早上打开邮件一看，GOOD NEWS!! Ref.:Ms. No. A-08-2015R1 Formation mechanism of lamellar chip in machining bulk metallic glass Acta Materialia Dear ...... I am pleased to inform you that your manuscript has now been accepted for publication. ................. Thank you for publishing your article in Acta Materialia. Yours sincerely, ......... Processing Editor Acta Materialia 这么短时间肯定没有再次送给审稿人看了，这位副主编就作了接受的决定。 看来，以后在投稿过程中，还是不能小视主编、副主编等， 因为他们一般也是科学家，非常熟悉领域动态的。 通过此次投稿还总结了一条成功的经验： 你想你的文章中Acta Mater，那就按Nat Mater来准备吧！
标签: 稿件
